| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.091 | 0.06 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.31 | 0.06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |